{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:01:16Z","timestamp":1776913276888,"version":"3.51.2"},"reference-count":14,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vaccine.2022.02.078","type":"journal-article","created":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T17:46:13Z","timestamp":1647539173000},"page":"2462-2469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Managing multiplicity in clinical vaccine studies \u2013 A case study using a gatekeeping testing strategy"],"prefix":"10.1016","volume":"40","author":[{"given":"Huajun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Ypma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.02.078_b0005","doi-asserted-by":"crossref","unstructured":"Dmitrienko A, Tamhane AC, Bretz F (Eds.), Multiple Testing Problems in Pharmaceutical Statistics (1st ed.). New York: Chapman and Hall\/CRC; 2010.","DOI":"10.1201\/9781584889854"},{"key":"10.1016\/j.vaccine.2022.02.078_b0010","unstructured":"US Food & Drug Administration. Multiple Endpoints in Clinical Trials Guidance for Industry. Draft. FDA-2016-D-4460. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/multiple-endpoints-clinical-trials-guidance-industry. [accessed 26 July 2021]."},{"key":"10.1016\/j.vaccine.2022.02.078_b0015","unstructured":"Committee for Human Medicinal Products. Guideline on multiplicity issues in clinical trial. Draft. EMA\/CHMP\/44762\/2017"},{"key":"10.1016\/j.vaccine.2022.02.078_b0020","unstructured":"US Food & Drug Administration. Multiple Endpoints in Clinical Trials Guidance for Industry. Draft. FDA-2016-D-4460."},{"issue":"6","key":"10.1016\/j.vaccine.2022.02.078_b0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J Thorac Dis."},{"issue":"22","key":"10.1016\/j.vaccine.2022.02.078_b0030","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/sim.2873","article-title":"Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies","volume":"26","author":"Hommel","year":"2007","journal-title":"Stat Med."},{"issue":"12","key":"10.1016\/j.vaccine.2022.02.078_b0035","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/sim.2716","article-title":"Tree-structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives","volume":"26","author":"Dmitrienko","year":"2007","journal-title":"Stat Med."},{"issue":"4","key":"10.1016\/j.vaccine.2022.02.078_b0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/sim.3495","article-title":"A graphical approach to sequentially rejective multiple test procedures","volume":"28","author":"Bretz","year":"2009","journal-title":"Stat Med."},{"issue":"3","key":"10.1016\/j.vaccine.2022.02.078_b0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/pst.291","article-title":"Gatekeeping procedures with clinical trial applications","volume":"6","author":"Dmitrienko","year":"2007","journal-title":"Pharm Stat."},{"issue":"1","key":"10.1016\/j.vaccine.2022.02.078_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1544-6115.1437","article-title":"Weighted multiple hypothesis testing procedures","volume":"8","author":"Kang","year":"2009","journal-title":"Stat Appl Genet Mol Biol."},{"issue":"5","key":"10.1016\/j.vaccine.2022.02.078_b0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/bimj.200710464","article-title":"General multistage gatekeeping procedures","volume":"50","author":"Dmitrienko","year":"2008","journal-title":"Biom J."},{"key":"10.1016\/j.vaccine.2022.02.078_b0060","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/sim.5711","article-title":"Memory and other properties of multiple test procedures generated by entangled graphs","volume":"32","author":"Maurer","year":"2013","journal-title":"Stat Med."},{"key":"10.1016\/j.vaccine.2022.02.078_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidential or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"issue":"32","key":"10.1016\/j.vaccine.2022.02.078_b0070","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1016\/j.vaccine.2015.06.079","article-title":"Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old children","volume":"33","author":"Vesikari","year":"2015","journal-title":"Vaccine."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:59Z","timestamp":1759403519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22002444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":14,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0264410X22002444"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing multiplicity in clinical vaccine studies \u2013 A case study using a gatekeeping testing strategy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.02.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 GlaxoSmithKline Biologicals S.A. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}